According to QY Research Medical, the contrast injector systems market size is expected to be worth around $1.5 billion by 2030, growing at a CAGR of 7.6% from 2021 to 2030.
According to QY Research Medical, the contrast injector systems market size is expected to be worth around $1.5 billion by 2030, growing at a CAGR of 7.6% from 2021 to 2030.
A contrast injector system is a medical diagnostic device that makes use of a contrast media to create visual representations of the interior of the human body to diagnose, monitor, or treat clinical disorders. The key imaging process includes, computed tomography, magnetic resonance imaging, and angiography. The contrast media enhances the contrast structures or visibility of fluids within the body as compared to traditional image processing. For instance, it is used to improve the visibility of blood vessels and gastrointestinal tract. These systems include various components, such as injector systems, consumables, and accessories. Consumables consist of injector head, syringes, tubing, and other consumables, whereas, accessories consist of hand switch, extension cable, face plate assembly, pressure jacket, syringe assembly, heater blanket assembly, coiled hand switch, and remote hand switch bracket.
Full Report is Ready | Request Sample of This Report @ https://qyresearchmedical.com/sample/112660
Contrast injector system is expected to exhibit significant market growth during the forecast period, owing to increase in imaging procedures and rapid incidence of various chronic diseases, such as cancer, heart diseases, Alzheimer’s, and dementia. The key factors that drive the growth of market increase in geriatric population coupled with high prevalence of chronic diseases globally. However, high cost of contrast injectors systems and high risk associated with contrast injector system are expected to restrict the market growth. Moreover, surge in healthcare expenditure and emergence of complex diseases in developing countries are expected to create lucrative opportunities for key market players.
The contrast injector system market is segmented on the basis of product type, application, end user, and region. According to product type, the market is divided into injector systems, consumables, and accessories. On the basis of application, the market is divided into interventional radiology, interventional cardiology, and radiology. On the basis of end user, the market is divided into diagnostic centers, clinics, hospitals, and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).
Scope of the Report
| Report Coverage | Details |
| Market Size in 2020 | $755.57 Million |
| Revenue Forecast by 2030 | $1.5 Billion |
| CAGR | 7.6% from 2021 to 2030 |
| Base Year | 2021 |
| Forecast Data | 2022 to 2030 |
Product Type Segment Review
By type, the contrast injector system market is divided into injector systems, consumables, and accessories. The consumables segment was the major revenue contributor in 2020, and is anticipated to continue this trend during the forecast period, owing to the growth in number of imaging procedures, such as CT, MRI, and angiography. On the other side, the demand for injector system is projected to exhibit the fastest market growth during the forecast period, owing to rise in incidence of chronic ailments such as various types of cancer, Alzheimer’s, and dementia, and other diseases, which is expected to create a demand for diagnostic procedures for precise treatment.
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112660/2900
Application Segment Review
By application, the contrast injector systems market size classified as interventional radiology, interventional cardiology, and radiology. The interventional radiology segment presently dominates the contrast injector systems market size, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth of contrast injector systems market share, owing to reduced risks, lower cost, and higher level of comfort, shorter hospital stays, and quicker recover. In addition, different diagnostic procedures that can be performed using interventional radiology include, angiography, cholangiography, and biopsy.
End User Segment Review
By end user, the contrast injector systems industry is classified as diagnostic centers, clinics, hospitals, and others. The hospitals segment presently dominates the contrast injector systems market forecast, and is expected to remain dominant during the forecast period. This segment is expected to exhibit a prominent growth rate of contrast injector systems market opportunity owing to adoption of latest imaging technologies at the earliest to offer effective examination of functional areas, which were not visible by older or conventional technologies. These factors are driving the contrast injector systems market growth.
Region Segment Review
By region, the contrast injector system market is analyzed across North America, Asia-Pacific, Europe, and LAMEA. North America dominated the contrast injector systems industry in 2020, accounting for the highest contrast injector systems market share, and is anticipated to maintain this trend during the forecast period. The research activities for contrast injector system are soaring in North America, owing to the well-established healthcare facilities, recent technological advancements, and rise in demand for early diagnosis of chronic diseases due to increase in awareness regarding contrast injectors.
This report provides comprehensive competitive analysis and profiles of prominent market players, such as key players operating in Bracco Imaging S.p.A, Bayer HealthCare, Guerbet Group, Medtron AG, Ulrich GmbH & Co. KG, GE Healthcare, Shenzhen Seacrown Electromechanical Co., Ltd., NemotoKyorindo Co. Ltd., Sino Medical- Device Technology Co., Ltd., and Vivid Imaging.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the contrast injector systems market analysis from 2020 to 2030 to identify the prevailing contrast injector systems market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the contrast injector systems market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global contrast injector systems market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
- By Product Type
- Consumables
- Injector Systems
- Accessories
- By Application
- Radiology
- Interventional Radiology
- Interventional Cardiology
- By End User
- Clinics
- Others
- Hospitals
- Diagnostics centers
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- North America
Key Market Players
- Bracco Imaging S.p.A
- bayer healthcare
- Guerbet Group
- Medtron AG
- Ulrich GmbH & Co. KG
- GE Healthcare
- Shenzhen Seacrown Electromechanical Co., Ltd.
- NemotoKyorindo Co. Ltd.
- Sino Medical- Device Technology Co., Ltd.
- Vivid Imaging
Quick Buy This Premium Report From Here: https://qyresearchmedical.com/report/checkout/112660/2900
You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333
About Us
QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.
For Latest Update Follow Us:
https://www.linkedin.com/company/qyresearch-medical/
https://www.facebook.com/QYResearch-Medical-108186514228917/